Efficacy and with type 2 diabetes inadequately controlled with metoformin (CANTATA-SU): 52 week results from a randomized, double-blind, phase 3 non-inferiority trial - Cefalu, W T; Leiter, L A; Yoon, K H (Lancet, 2013)
et al.